来自于 发表于 2025-3-26 23:29:10

http://reply.papertrans.cn/1/50/4981/4981-31.png

Thrombolysis 发表于 2025-3-27 01:36:17

http://reply.papertrans.cn/1/50/4981/4981-32.png

Lineage 发表于 2025-3-27 07:28:49

Submitted on: 10 April 1998.
Revised on: 12 July 1998.
Accepted on: 04 September 1998.

___________________Cellular Reprogramming---MARY ANN LIEBERT, INC

scoliosis 发表于 2025-3-27 11:28:54

Submitted on: 26 March 2024.
Revised on: 08 May 2024.
Accepted on: 28 June 2024.

___________________Cellular Reprogramming---MARY ANN LIEBERT, INC

Ambulatory 发表于 2025-3-27 13:57:40

Submitted on: 05 March 2019.
Revised on: 06 May 2019.
Accepted on: 23 May 2019.

___________________Cellular Reprogramming---MARY ANN LIEBERT, INC

Axon895 发表于 2025-3-27 21:14:10

Submitted on: 23 August 2009.
Revised on: 25 October 2009.
Accepted on: 21 November 2009.

___________________Cellular Reprogramming---MARY ANN LIEBERT, INC
页: 1 2 3 [4]
查看完整版本: SCIE期刊Cellular Reprogramming 2024/2025影响因子:1.246 (CELL REPROGRAM) (2152-4971). (BIOTECHNOLOGY & APPLIED MICROBIOLOGY)(生